Atea Pharmaceuticals (AVIR)
(Delayed Data from NSDQ)
$3.96 USD
+0.13 (3.39%)
Updated May 3, 2024 04:00 PM ET
After-Market: $3.95 -0.01 (-0.25%) 7:58 PM ET
3-Hold of 5 3
C Value D Growth B Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/13/2024
Time: -- |
3/2024 | $-0.61 | 0.00% |
Earnings Summary
For their last quarter, Atea Pharmaceuticals (AVIR) reported earnings of -$0.47 per share, missing the Zacks Consensus Estimate of -$0.44 per share. This reflects a negative earnings surprise of 6.82%. Look out for AVIR's next earnings release expected on May 13, 2024. For the next earning release, we expect the company to report earnings of -$0.61 per share, reflecting a year-over-year decrease of 41.86%.
Earnings History
Price & Consensus
Zacks News for AVIR
Atea Pharmaceuticals, Inc. (AVIR) Moves to Buy: Rationale Behind the Upgrade
AVIR: What are Zacks experts saying now?
Zacks Private Portfolio Services